Republicans Shift from War on Drugs to Psyelic Advocacy for Mental Health
You hit a paywall. Here’s the context on this topic based on publicly available information. We did not access any paywalled content. View original article.
Republicans Shift from War on Drugs to Psyelic Advocacy for Mental Health
- A growing number of Republicans, including 68 members of Congress, now support federal reforms to enable psychedelic research and therapies for mental health conditions like PTSD.
- In late March 2025, former Texas Governor Rick and ibogaine advocate. Bryan Hubbard appeared on Joe Rogan's podcast urging Rogan to request a meeting with President Trump on psychedelics.
Full Summary — powered by AI
Republicans, long champions of the “war on drugs” initiated in the 1970s under President Richard Nixon, are increasingly embracing psychedelics such as psilocybin, MDMA, and ibogaine as potential treatments for mental health issues, particularly among veterans.
This pivot reflects a bipartisan trend but has gained notable traction on the right. High-profile GOP figures like Rick Perry, who served as Texas governor from 2000 to 2015 and briefly as U.S. Energy Secretary, have become vocal proponents. Perry, alongside W. Bryan Hubbard of the American Ibogaine Initiative, taped an episode of Joe Rogan’s popular podcast in late March 2025. During the show, they made headlines by asking Rogan to facilitate a meeting with President Donald Trump to discuss easing restrictions on these substances.
Veterans’ advocacy has been pivotal. Groups like the Veteran Mental Health Leadership Coalition report that over 20 veterans die by suicide daily, fueling calls for alternatives to traditional treatments. Clinical trials, including FDA-designated breakthrough therapies for MDMA-assisted psychotherapy in 2017 and psilocybin for depression in 2018, show promise: a 2023 Johns Hopkins study found psilocybin as effective as SSRIs for major depression with fewer side effects.
Legislatively, the GOP’s stance is evident in the 2024 introduction of the Breakthrough Therapies Act by Reps. Dan Crenshaw (R-Texas) and Ritchie Torres (D-N.Y.), backed by 68 bipartisan cosponsors. States like Texas, under Perry’s influence, have funded ibogaine clinics for veterans since 2024. Utah and Oklahoma, both red states, legalized certain psychedelic therapies earlier.
The shift stems from personal stories—veterans crediting psychedelics with life-changing relief—and economic arguments, with the psychedelic therapy market projected to reach $11 billion by 2032 per Grand View Research. Critics, including some conservatives, warn of risks like hallucinations and lack of long-term data, but momentum builds ahead of potential 2026 FDA decisions on MDMA approval.
(Word count: 278)